Abstract:Abstract Background The small number of samples and the curse of dimensionality hamper the better application of deep learning techniques for disease classification. Additionally, the performance of clustering-based feature selection algorithms is still far from being satisfactory due to their limitation in using unsupervised learning methods. To enhance interpretability and overcome this problem, we developed a novel feature selection algorithm. In the meantime, complex genomic data brought great challenges for the identification of biomarkers and therapeutic targets. The current some feature selection methods have the problem of low sensitivity and specificity in this field. Results In this article, we designed a multi-scale clustering-based feature selection algorithm named MCBFS which simultaneously performs feature selection and model learning for genomic data analysis. The experimental results demonstrated that MCBFS is robust and effective by comparing it with seven benchmark and six state-of-the-art supervised methods on eight data sets. The visualization results and the statistical test showed that MCBFS can capture the informative genes and improve the interpretability and visualization of tumor gene expression and single-cell sequencing data. Additionally, we developed a general framework named McbfsNW using gene expression data and protein interaction data to identify robust biomarkers and therapeutic targets for diagnosis and therapy of diseases. The framework incorporates the MCBFS algorithm, network recognition ensemble algorithm and feature selection wrapper. McbfsNW has been applied to the lung adenocarcinoma (LUAD) data sets. The preliminary results demonstrated that higher prediction results can be attained by identified biomarkers on the independent LUAD data set, and we also structured a drug-target network which may be good for LUAD therapy. Conclusions The proposed novel feature selection method is robust and effective for gene selection, classification, and visualization. The framework McbfsNW is practical and helpful for the identification of biomarkers and targets on genomic data. It is believed that the same methods and principles are extensible and applicable to other different kinds of data sets.

Specific feature recognition on group specific networks (SFR-GSN): a biomarker identification model for cancer stages

Integrating Prior Knowledge Into Prognostic Biomarker Discovery based on Network Structure

Identifying network biomarkers of cancer by sample-specific differential network

A three-stage approach to identify biomarker signatures for cancer genetic data with survival endpoints

Effective Cancer Subtype and Stage Prediction via Dropfeature-DNNs

Multi-scale supervised clustering-based feature selection for tumor classification and identification of biomarkers and targets on genomic data

Network-based identification of biomarkers for colon adenocarcinoma

Biomarkers discovery for endometrial cancer: A graph convolutional sample network method

NNBGWO-BRCA marker: Neural Network and binary grey wolf optimization based Breast cancer biomarker discovery framework using multi-omics dataset

Using a machine learning approach to identify key prognostic molecules for esophageal squamous cell carcinoma

An ensemble learning-based feature selection algorithm for identification of biomarkers of renal cell carcinoma

Identification of Key Biomarkers and Candidate Molecules in Non-Small-Cell Lung Cancer by Integrated Bioinformatics Analysis

FS–GBDT: identification multicancer-risk module via a feature selection algorithm by integrating Fisher score and GBDT

Non-invasive decision support for clinical treatment of NSCLC using a multiscale radiomics approach

Deep Fuzzy Neural Networks for Biomarker Selection for Accurate Cancer Detection

Network as a Biomarker: A Novel Network-Based Sparse Bayesian Machine for Pathway-Driven Drug Response Prediction

Identification of blood protein biomarkers for breast cancer staging by integrative transcriptome and proteome analyses

Breast cancer prognostic biomarker using attractor metagenes and the FGD3-SUSD3 metagene

Identidication of novel biomarkers in non-small cell lung cancer using machine learning

Novel image markers for non-small cell lung cancer classification and survival prediction

Enhanced Cancer Classification and Critical Feature Visualization Using Raman Spectroscopy and Convolutional Neural Networks